NCT06066580Phase 2Enrolling by invitation

Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

Study sponsor: Edgewise Therapeutics, Inc. · EWTX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2031-02Estimated
Enrollment · participants260Estimated
Source updated2026-09-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Aug 2029. After: Feb 2031.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview